28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Discussion 205<br />

Discussion 205<br />

tried mixing the viruses experi-<br />

DR. SABIN: With reference to the question that<br />

Dr. Dick asked of Dr. Kimball, about the evidence<br />

for multiplication of poliovirus in children that<br />

may have been adequately immunized with properly<br />

spaced doses of Salk vaccine of proper<br />

potency, I carried out a rather extensive study<br />

in association with Dr. Krugman and others.<br />

This study was reported only in abstract form in<br />

the British Medical Journal and also in another<br />

review article.<br />

Then we<br />

mentally, i.e., ECHO-1, and polio 1. If we put in<br />

a little more poliovirus than ECHO-1, we ended<br />

up by getting only poliovirus after two or three<br />

passages. If we put in a little more poliovirus<br />

than ECHO-1, after two or three passages in<br />

tissue culture, we again got only the one that<br />

was originally there in larger quantity.<br />

I therefore believe that this should be kept in<br />

mind in interpreting, or attempting to interpret,<br />

the data represented by possible virus interference.<br />

The persons who were not found to excrete<br />

poliovirus Type 1, let us say, after being fed Type<br />

1, might have been found excreting poliovirus<br />

had the other enterovirus that was found been<br />

neutralized and a search then made for poliovirus.<br />

DR. HORSTMANN: I did understand Dr.<br />

Hammon's questions. I merely wished to point<br />

out that we were aware of the problem outlined<br />

by Dr. Hammon, but attempted to overcome it by<br />

using another technique. By means of the plaque<br />

method applied to the original fecal suspension,<br />

we were able to pick up small amounts of poliovirus<br />

or other enteroviruses which might have<br />

been overgrown in tissue-culture tubes.<br />

Apparently, with the particular ECHO viruses<br />

which were prevalent during our trial, this<br />

problem did not occur in the same way that it<br />

occurred with Dr. Hammon's Type 1 ECHO<br />

virus. We found both ECHO and polioviruses to<br />

be present in only small quantities. So that, after<br />

extensive tests, we concluded that overgrowth of<br />

one virus by another was not a significant problem<br />

with our material, and returned, therefore,<br />

to tube cultures.<br />

I believe it is also worth mentioning that subsequently<br />

we did isolate a number of ECHO and<br />

polioviruses in the same specimen grown in tissue-culture<br />

tubes. The other point which gives<br />

us confidence in the methods used is that antibody<br />

development and the isolation of viruses correlated<br />

so extraordinarily well, within 1 or 2 per<br />

cent of one another; therefore, we feel it is very<br />

unlikely that we missed any polioviruses in the<br />

specimens under the circumstances under which<br />

Dr. Hammon has suggested this might have<br />

occurred.<br />

We selected, first of all, children without<br />

demonstrable antibody before Salk vaccine.<br />

Three doses of Salk vaccine were then given over<br />

a one-year period, with the proper intervals, and<br />

then a summer period went by and they were<br />

tested at frequent intervals during that time.<br />

Because in some of the children there was a drop<br />

in antibody which had appeared after the three<br />

doses, we obtained a particularly potent Salk<br />

vaccine, that was not a commercially-distributed<br />

one, and gave them all a fourth dose.<br />

We thus accumulated a group of about 25<br />

children, most of whom had rather high antibody<br />

titers-many of them 256 to 512 for Types 1<br />

and 3.<br />

They were then fed either Type 1 or Type 3<br />

vaccine, and the multiplication of viruses was<br />

followed quantitatively over a period of more<br />

than eight weeks. The multiplication of Type 1<br />

and Type 3 virus in them was no different from<br />

that in children without any demonstrable antibody.<br />

Furthermore, the antibody response, the<br />

booster response to this multiplication, did not<br />

occur any faster than in children who had not<br />

previously had any Salk vaccine.<br />

We came to the conclusion that with potent<br />

vaccine and four doses, and the antibody produced<br />

at the level indicated, we found no interference<br />

with multiplication of virus.<br />

DR. BODIAN: Since the subject at this time is<br />

the spread of polioviruses, I think it important to<br />

contribute to this discussion something which I<br />

believe has been missing. I believe that a few<br />

years ago Dr. Howe came closest to presenting<br />

what I consider a rational approach to the problem<br />

of inhibition of virus excretion, namely an<br />

assessment of the role of antibody. Dr. Howe<br />

attempted to find the level of antibody which<br />

would inhibit this phenomenon of infection.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!